Kotak 
Dealstreet

Kotak PE invests 400 crore in Biorad Medisys: Luthra advises

Bar & Bench

Kotak Strategic Situations India Fund II, managed by Kotak Alternate Asset Managers Limited, has made an investment of up to ₹400 Crore in medical device manufacturer Biorad Medisys Private Limited.

Luthra and Luthra Law Offices India represented Kotak in this investment deal.

The transaction team consisted of Nishant Singh (Partner), Prachi Pandit (Managing Associate), Saksham Madan (Managing Associate), Manushi Shah (Associate), Varshini Ramesh (Associate), Aditi Nagpal (Associate), Charith Reddy (Associate), Kashish Singhal (Associate), Maitri Meghani (Associate) and Aashi Shah (Associate).

Nishant Singh

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Also Read

Husband's niece cannot be implicated in domestic violence case: Bombay High Court

Bombay High Court slaps ₹5 lakh costs on litigant for "taking a chance" by filing writ petition

Professionally qualified wives can't automatically be denied maintenance: Punjab & Haryana High Court

TN Speaker moves Madras High Court challenging defamation case filed by AIADMK leader

Siddha professionals can practice modern medicine but can’t store allopathy drugs: Madras High Court

SCROLL FOR NEXT